Your Article Summary
See Latest ArticlesMethotrexate therapy for juvenile rheumatoid arthritis in Japan -- surveillance with a questionnaire at seven main facilities
Modern Rheumatology, 06/19/09
Aihara Y et al. – Study reports that the methotrexate (MTX) therapy was applied broadly to juvenile rheumatoid arthritis (JRA) patients in Japan. The therapy was determined to be more effective than prior medications when combined with other drugs.
Methods- Study to investigate the current state of therapy for JRA in Japan
- In Sept 1996 a questionnaire about MTX therapy was sent to the main facilities in Japan
- From 7 main facilities, a total of 56 JRA pts treated with MTX were reported
- MTX was used frequently for the treatment of pts with JRA in combination with other drugs such as NSAIDs and prednisolone
- MTX therapy was determined effective in 80% of cases; was tolerable in most cases
- However, there were a few mild adverse effects including hepatotoxicity
Related Articles
Evaluation of bone mineral density and bone turnover markers in Egyptian children with juvenile rheumatoid arthritis
Archives of Medical Science, 11/03/09
Relevance Score: 80%
New Treatment Combination Promising for Children with Arthritis
MedLinePlus, 11/03/09
Relevance Score: 80%
Dynamics of body composition and bone in patients with juvenile idiopathic arthritis treated with growth hormone
Journal of Clinical Endocrinology and Metabolism, 11/10/09
Relevance Score: 79%
Analysis of quantitative ultrasound graphic trace and derived variables assessed at proximal phalanges of the hand in healthy subjects and in patients with cerebral palsy or juvenile idiopathic arthritis. A pilot study
Bone, 10/08/09
Relevance Score: 79%
Longitudinal analysis of complementary and alternative health care use in children with juvenile idiopathic arthritis
Complementary Therapies in Medicine, 10/26/09
Relevance Score: 78%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Interferon-[alpha] mediates suppression of C-reactive protein: Explanation for muted C-reactive protein response in lupus flares?
Arthritis & Rheumatism, 12/07/09
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
Journal of Dermatological Treatment , 12/07/09
Today in Pediatric Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of juvenile idiopathic arhrtitis and functional constipation
International Journal of Clinical Rheumatology, 12/04/09
Systemic vasculitis in childhood
Current Rheumatology Reports, 12/03/09
Plasma level of myeloperoxidase in children with juvenile idiopathic arthritis (a pilot study)
Central European Journal of Medicine, 11/25/09
Today in Rheumatoid Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study
Arthritis & Rheumatism, 12/07/09
Neurologic outcome of surgical and conservative treatment of rheumatoid cervical spine subluxation: A systematic review
Arthritis Care and Research , 12/07/09
Comparison of autoinflammation and autoimmunity using TRAPS and rheumatoid arthritis as prototypes of these conditions
International Journal of Clinical Rheumatology, 12/04/09